cpx-351
Cpx 351 is a drug used to treat Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic Syndrome (MDS), and other conditions. Cpx 351 is being actively studied in 19 studies and prior, has been studied in 8.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| Jazz Pharmaceuticals | Medical College of Wisconsin | Sudipto Mukherjee |
| Weill Medical College of Cornell University | Weill Cornell Medical College | Deepa Jeyakumar |
| Case Comprehensive Cancer Center | Fred Hutchinson Cancer Research Center | Laura Michaelis |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
- Acute Myeloid Leukemia
- AML
- Palcociclib
- CPX-351
- Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
2022-03-16
Mar 16, 2022G
Recruiting
- Acute Myeloid Leukemia (AML) in Remission
- CPX-351
- Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
2022-02-07
Feb 7, 2022C
Recruiting
- Refractory Acute Myeloid Leukemia
- +2 more
- CPX-351
- Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
2022-03-15
Mar 15, 2022W
Active, not recruiting
- Myelodysplastic Syndromes
- CPX-351
- +3 more
- Tampa, Florida
- +2 more
2022-04-01
Apr 1, 2022Y
Withdrawn
- MDS
- CPX-351
- New Haven, ConnecticutYale University; Smilow Cancer Center
2022-01-06
Jan 6, 2022W
Active, not recruiting
- Myelodysplastic Syndromes
- +3 more
- CPX-351
- +4 more
- New York, New YorkWeill Cornell Medical College
2022-01-26
Jan 26, 2022W
Active, not recruiting
- Leukemia, Myeloid, Acute
- CPX-351
- New York, New YorkWeill Cornell Medical College
2021-12-10
Dec 10, 2021C
Recruiting
- Myelodysplastic Syndrome (MDS)
- CPX-351
- Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
2021-04-21
Apr 21, 2021J
Recruiting
- Acute Myeloid Leukemia
- CPX-351
- Belfast, United Kingdom
- +14 more
2022-04-05
Apr 5, 2022S
J
J
Completed
- Hematologic Malignancy
- +4 more
- CPX-351
- Washington, District of Columbia
- +12 more
2021-07-20
Jul 20, 2021U
Recruiting
- Acute Myelogenous Leukemia (AML) Due to Therapy
- Acute Myeloid Leukemia With Myelodysplasia-Related Changes
- Glasdegib
- CPX-351
- La Jolla, California
- +2 more
2021-04-09
Apr 9, 2021J
Active, not recruiting
- Acute Myeloid Leukemia
- CPX-351
- +3 more
- Duarte, California
- +9 more
2022-03-07
Mar 7, 2022W
Recruiting
- Acute Myeloid Leukemia
- CPX-351
- Gemtuzumab Ozogamicin
- New York, New YorkWeill Cornell Medical College
2021-12-21
Dec 21, 2021C
Completed
- Acute Myeloid Leukemia
- +7 more
- CPX-351
- Cincinnati, OhioCincinnati Children's Hospital Medical Center
2020-11-06
Nov 6, 2020P
Active, not recruiting
- Newly Diagnosed Secondary or High Risk AML
- CPX-351
- Badalona, Spain
- +11 more
2021-07-09
Jul 9, 2021M
Recruiting
- Leukemia, Myeloid, Acute
- Outpatient Care Model
- CPX-351
- Milwaukee, WisconsinFroedtert Hospital
2021-05-24
May 24, 2021H
Active, not recruiting
- Lymphoid Leukemia
- +3 more
- CPX-351
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-09-14
Sep 14, 2021B
Not yet recruiting
- Acute Myeloid Leukemia
- CPX-351
- +5 more
- Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
2022-02-21
Feb 21, 2022F
Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm
Not yet recruiting
- Acute Myeloid Leukemia
- Myeloproliferative Syndrome
- CPX-351
- Amiens, France
- +33 more
2022-02-07
Feb 7, 2022U
G
Recruiting
- MDS
- AML
- CPX-351
- +3 more
- Linz, Austria
- +26 more
2021-08-18
Aug 18, 2021J
Completed
- High Risk Acute Myeloid Leukemia
- CPX-351
- 7+3 (cytarabine and daunorubicin)
- Birmingham, Alabama
- +42 more
2020-07-28
Jul 28, 2020J
Completed
- Acute Myeloid Leukemia With Myelodysplasia-Related Changes
- Therapy-Related Acute Myeloid Leukemia
- CPX-351
- Indianapolis, Indiana
- +6 more
2020-08-04
Aug 4, 2020